Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/10/2002WO2002024868A3 Non-human model of gestational and adult folate deficiency and uses thereof
10/10/2002WO2002016419A3 Progression suppressed gene 13 (psgen 13) and uses thereof
10/10/2002WO2002012481A3 Enhancement of industrial production by increasing substrate transport
10/10/2002WO2002010766A3 Assay method, peptides and reagent kits for testing mrp-specific inhibitors
10/10/2002WO2002006321A3 Polycomb gene zmfie2 from maize
10/10/2002WO2002004007A9 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
10/10/2002WO2002002599A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF
10/10/2002WO2002000714A3 Receptor for phosphoinositides-1 associated scaffold protein
10/10/2002WO2002000694A3 Modified morbillivirus v proteins
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001095929A3 Interferon for treatment of multiple sclerosis
10/10/2002WO2001094412A9 56201, a novel human sodium ion channel family member and uses thereof
10/10/2002WO2001090340A3 Assembly of large viral genomes and chromosomes from subclones
10/10/2002WO2001090307A9 Intraflagellar transport
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001076529A9 Fertility associated antigen and methods of use thereof
10/10/2002WO2001073017A3 Regulation of human adp-ribosylation factor-related protein
10/10/2002WO2001066755A3 Monocotyledonous plant genes and uses thereof
10/10/2002WO2001064869A3 Tumor-related antigen
10/10/2002WO2001053324A8 Novel haptotactic peptides
10/10/2002WO2000047102A3 COMPOSITIONS AND METHODS FOR MODULATING TGF-β SIGNALING
10/10/2002WO2000000601A3 Production of low-temperature, salt-and drought-tolerant transgenic cereal plants
10/10/2002US20020148008 Nucleotide sequences coding protein for use in controlling latency in plants
10/10/2002US20020148007 Seed-preferred promoter from barley
10/10/2002US20020148004 Modification of a plant disease resistance gene specificity and method for engineering altered specificity
10/10/2002US20020148001 Expression vector for use in the generation of animal models for analysis of genetic disorders
10/10/2002US20020147999 Reducing neuronal tangles in alzhemier's patients; obtain human, administer modulator, monitor development of neuronal tangles in, reduction in neuronal tangles indicates modulator
10/10/2002US20020147996 Diagnosing and treating cancer cells using Sal2
10/10/2002US20020147371 Forming lycopene; genetic engineering; culture product
10/10/2002US20020147329 Method of modulating tissue growth using Frzb protein
10/10/2002US20020147328 Connective tissue growth factor homologs
10/10/2002US20020147327 Glucocorticoid receptor protein for use in the treatment of arthritis and asthma
10/10/2002US20020147326 Fusion protein for use in the treatment of autoimmune diseases tissue grafting defect
10/10/2002US20020147325 Antibodies to receptor protein kinases
10/10/2002US20020147324 RPS gene family, primers, probes, and detection methods
10/10/2002US20020147322 Nucleotide sequences coding polypeptides for use in the prevention, diagnosis and treatment of cancer
10/10/2002US20020147321 Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained
10/10/2002US20020147314 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory bowel disease
10/10/2002US20020147311 Fusion protein for use in the treatment of tumors
10/10/2002US20020147310 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases
10/10/2002US20020147309 Human N-type calcium channel isoform and uses thereof
10/10/2002US20020147308 Human vomeronasal receptor
10/10/2002US20020147307 Therapeutic and diagnostic agents comprising a socs box
10/10/2002US20020147306 Peptides that modulate the interaction of B class ephrins and PDZ domains
10/10/2002US20020147305 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002US20020147304 Non-naturally occurring lipoprotein particle
10/10/2002US20020147303 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
10/10/2002US20020147302 Liquid phase peptide synthesis of KL-4 pulmonary surfactant
10/10/2002US20020147173 Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies
10/10/2002US20020147172 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
10/10/2002US20020147170 Constitutively active, hypersensitive, and nonfunctional recepors as novel therapeutic agents
10/10/2002US20020147167 Hybrid nucleic acid; viricides
10/10/2002US20020147162 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (PTTG)
10/10/2002US20020147161 Novel antisense inhibition of rad51
10/10/2002US20020147154 Cosmetic, drugs; extraction, precipitation, washing
10/10/2002US20020147151 IL-16 antagonists
10/10/2002US20020147149 Cytostatin III
10/10/2002US20020147148 Insecticidal protein toxins from xenorhabdus
10/10/2002US20020147147 Aids therapy
10/10/2002US20020147146 Antidiabetic agents; Alzheimer's disease
10/10/2002US20020147144 Prevention, therapy autoimmune diseases; anticholesterol agents
10/10/2002US20020147143 Diagnosis, therapy; anticancer agents
10/10/2002US20020147140 Nucleic acids, proteins, and antibodies
10/10/2002US20020147139 Viricides
10/10/2002US20020147137 Medical use of alpha1-acid glycoprotein (AAG) or orosomucoid
10/10/2002US20020147132 Meltrins
10/10/2002US20020147129 Polypeptides; nervous system, brain disorders
10/10/2002US20020146843 Controlling protein levels in eucaryotic organisms
10/10/2002US20020146824 Novel transcription enhancer element and transcription factor and methods of use thereof
10/10/2002US20020146820 Immunoreactive peptide CTL epitopes of human cytomegalovirus pp150
10/10/2002US20020146819 Human TSLP DNA and polypeptides
10/10/2002US20020146807 Polypeptides for use in the treatment of cancer; for use as wound healing agent
10/10/2002US20020146806 Nucleotide sequences coding polypeptides for use in the treatment of rheumatic and autoimmune diseases
10/10/2002US20020146803 Mutant protein for use as tool in genetic engineering
10/10/2002US20020146801 RNA polymerase I transcription factor TIF-IA
10/10/2002US20020146800 48921, a novel human GTP releasing factor and uses therefor
10/10/2002US20020146795 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
10/10/2002US20020146794 Recombinant human serum transferrins containing peptides for inducing apoptosis in HIV-1 infected cells
10/10/2002US20020146793 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering
10/10/2002US20020146792 Nucleotide sequences coding protein for use in the treatment of atherosclerosis
10/10/2002US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002US20020146789 Multi-domain proteinase inhibitor
10/10/2002US20020146782 Nucleotide sequences coding for the sigC gene
10/10/2002US20020146781 Nucleotide sequences coding for the thrE gene and process for the enzymatic production of L-threonine using coryneform bacteria
10/10/2002US20020146779 Methods for production of recombinant polypeptides
10/10/2002US20020146778 Nucleotide sequences coding polypeptides for use as tools in human therapeutics and diagnostics
10/10/2002US20020146777 Canine parathyroid hormone 1 receptor
10/10/2002US20020146776 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bacterial infections
10/10/2002US20020146775 Novel semaphorin genes (I)
10/10/2002US20020146774 Smad2 phosphorylation and interaction with Smad4
10/10/2002US20020146773 ''Signalin'' family of TGFbeta signal transduction proteins, and uses related thereto
10/10/2002US20020146772 Nucleotide equences coding enzymatic polypeptide for use in the treatment of blood disorders and thrombosis
10/10/2002US20020146771 Process for producing erythropoietin containing no animal proteins
10/10/2002US20020146770 RAS proteins
10/10/2002US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002US20020146767 Human EMR1-like G protein-coupled receptor
10/10/2002US20020146766 Human vomeronasal receptor-3
10/10/2002US20020146765 Acetylcholine receptor subunits
10/10/2002US20020146764 Generation of preferential polypeptides; obtain expresion vector containing preferential fusion gene, express vector, recover fusion protein
10/10/2002US20020146763 Polypeptide for use in the human therapeutic and diagnostics
1 ... 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 ... 2916